Marchex (MCHX) Proxy Filing summary
Event summary combining transcript, slides, and related documents.
Proxy Filing summary
1 Dec, 2025Executive summary
The 2024 Annual Meeting is scheduled for October 30, 2024, with proposals to elect five directors and ratify the appointment of RSM US LLP as the independent auditor for 2024.
Voting materials are primarily distributed electronically to reduce costs and environmental impact.
Only holders of Class A and Class B common stock as of September 4, 2024, are eligible to vote, with Class A shares carrying 25 votes each and Class B shares one vote each.
The Board recommends voting FOR all director nominees and FOR the auditor ratification.
Voting matters and shareholder proposals
Proposal One: Elect five directors to serve until the next annual meeting.
Proposal Two: Ratify RSM US LLP as the independent registered public accounting firm for 2024.
Shareholders may submit proposals for the 2025 meeting by May 21, 2025, for inclusion in proxy materials.
Board of directors and corporate governance
The board consists of five members, with three considered independent under NASDAQ standards.
Board committees include Audit, Compensation, and Nominating and Governance, each with defined charters and independent membership.
The board emphasizes diversity in gender, race, experience, and skills, and conducts annual self-assessments.
Leadership structure is flexible, with recent changes including the appointment of a new CEO and Vice Chairman in 2023.
Latest events from Marchex
- Shareholders will vote on acquiring Archenia, with independent oversight and dual-majority approval required.MCHX
Proxy filing5 Jun 2026 - Shareholders to vote on acquiring Archenia for $10M in notes and up to 4M shares, with Board support.MCHX
Proxy filing26 May 2026 - AI-driven products, improved margins, and the Archenia deal set the stage for future growth.MCHX
Q1 202619 May 2026 - Board-approved Archenia acquisition aims to accelerate growth and margin expansion in 2026.MCHX
Proxy filing13 May 2026 - Acquisition of Archenia, Inc. for $10M in notes and up to 4M shares awaits stockholder approval.MCHX
Proxy filing12 May 2026 - 2025 revenue fell, but AI solutions and Archenia deal position for strong 2026 growth.MCHX
Q4 202530 Apr 2026 - Net loss narrowed and adjusted EBITDA improved as revenue is set to grow in Q3.MCHX
Q2 20242 Feb 2026 - Q3 2024 delivered $12.6M revenue, narrowed losses, and set the stage for AI-driven growth in 2025.MCHX
Q3 202417 Jan 2026 - 2025 is set for sequential growth and margin improvement, driven by new AI products and partnerships.MCHX
Q4 202424 Dec 2025